Syros Pharmaceuticals Inc. (NASDAQ: SYRS)
$6.52
+0.3800 ( +6.19% ) 87.1K
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
Market Data
Open
$6.52
Previous close
$6.14
Volume
87.1K
Market cap
$174.27M
Day range
$6.11 - $6.69
52 week range
$2.09 - $8.17
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Jun 06, 2024 |
| 4 | Insider transactions | 1 | Jun 04, 2024 |
| 4 | Insider transactions | 1 | Jun 04, 2024 |
| 10-q | Quarterly Reports | 79 | May 14, 2024 |
| ars | Annual reports | 1 | Apr 23, 2024 |
| def | Proxies and info statements | 7 | Apr 23, 2024 |
| pre | Proxies and info statements | 7 | Apr 12, 2024 |
| 4 | Insider transactions | 1 | Apr 05, 2024 |
| 4 | Insider transactions | 1 | Apr 02, 2024 |
| 4 | Insider transactions | 1 | Apr 02, 2024 |